European Federation of National Associations of Orthopaedics and Traumatology

Tweet this page
<
2019
2020
2021
2022
>
Registration as it was on 03 Mar 2021
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

75,000€

Financial year: Jan 2019 - Dec 2019

Lobbyists (Full time equivalent)

3 Fte (12)

Lobbyists with EP accreditation

0

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    European Federation of National Associations of Orthopaedics and Traumatology   (EFORT)

    EU Transparency Register

    241995833892-89 First registered on 27 Feb 2019

    Goals / Remit

    EFORT, the European Federation of National Associations of Orthopaedics and Traumatology, is the platform
    organisation linking Europe‘s national orthopaedic associations. Its aims reflect the will to promote the exchange of scientific knowledge and experience in the field of prevention and both the conservative and surgical treatment of diseases and injuries concerning the musculoskeletal system. Its mission is to work on behalf of the European Orthopaedic and Traumatology Community to restore and secure mobility, musculoskeletal health and through this, quality of life.

    Its strategy focusses on four pillars that support these aims: education, harmonisation of guidelines &
    standards, influencing European health policy, and finally research.

    The national associations of orthopaedics and traumatology from twenty European countries established EFORT by consensus. The Federation was founded in Marentino, Italy, in 1991, and today has 41 national member societies from 39 memb (...)

    Main EU files targeted

    EFORT’s various initiatives ambition to elevate the burden of musculoskeletal conditions in Europe to a recognized condition on the European agenda and to include it in research and public health activities, so to guide future EU strategies. There are today clear cross boarder inequalities and standards of care for treatment are still too disparate.

    Address

    Head Office
    ZA La Piece 2
    Rolle 1180
    SWITZERLAND
  • People

    Total lobbyists declared

    12

    Employment timeLobbyists
    25%12

    Lobbyists (Full time equivalent)

    3

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    III - Non-governmental organisations

    Subcategory

    Non-governmental organisations, platforms and networks and similar

  • Networking

    Affiliation

    EFORT is member of:
    Biomed Alliance www.biomedeurope.org
    AC Forum: www.acforum.net
    Health First Europe www.healthfirsteurope.eu

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2019 - Dec 2019

    Lobbying costs for closed financial year

    75,000€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    Medical Device Coordination Group#X03565#http://ec.europa.eu/transparency/regexpert/index.cfm?do=groupDetail.groupDetail&groupID=3565 #Observer #C#Professionals#03 - Clinical Investigation and Evaluation (CIE)

    Groups (European Parliament)

    -Observers in the new subgroups of the Medical Device Coordination Group (MDCG) and now also invited to participate in the meeting between MDCG and stakeholders
    -Invitation for EFORT to speak at the EU parliament (4 April) on "The importance of registers to determine the quality of implants and to stop usage of failing devices"
    -SCENIHR
    --Expert panels: EFORT chairs the Thematic panel for Orthopaedics, Traumatology, Rehabilitation,
    Rheumatology and has a representative in the Screening Panel

    Communication activities

    Trying to match EFORT’s initiatives notably based on the "10 political priorities of the Juncker Commission" in order to influence the European Health agenda in the field of musculoskeletal health would probably focus on the following aspects:
    - Job, Growth and investment
    - A deeper and fairer internal market with a strengthened industrial base
    - A balanced and progressive trade policy to harness globalisation

    EFORT has been active within the European Reference Network with a specific objective to make Health care systems effective, accessible and resilient (1.4 of the Management Plan 2018 for DG Health and Food Safety – SANTE). Similarly for increased access to medical expertise and information for specific conditions (1.5 of the Management Plan 2018 for DG Health and Food Safety – SANTE)

    As another activity NORE is an all-inclusive network that fosters international collaboration and co-ordination of learning and research in orthopaedics, with special focus on medical device surveillance, arthroplasty outcome, and other registries of orthopaedic conditions in order to support improvements in patient care. The specific objective 1.6: Effective, efficient and reliable official controls (Management Plan 2018 for DG Health and Food Safety – SANTE) proposes “to carry out approximately 40 joint assessments of notified bodies designated under the medical devices and in vitro diagnostic medical devices Regulations”. This ties into registry activities and is likely to firm EFORT’s position expressed in recently published statements:
    -New Medical Devices Regulations (MDR) and In Vitro Diagnostic Medical Devices Regulations (IVDR) - https://www.efort.org/mdr/

    -Are Orthopaedic and Trauma implants safe? - https://www.efort.org/efort-are-orthopaedic-and-trauma-implants-safe/

    Another good example is the specific objective 2.1: Effective EU assessment of medicinal products and other treatment (Management Plan 2018 for DG Health and Food Safety – SANTE). Through the EFORT affiliation to Biomed Alliance demonstrates our belief that a collaborative framework for the clinical assessment of health technologies is necessary to support high-quality healthcare in Europe.
    -European Doctors unite to demand policymakers support for EU-Level HTA - https://www.efort.org/jt-hta/

    Further EFORT was represented in the recently held JRC Ispra meeting on medical devices of 11 February aiming at the finalisation of the landscape of the expert panels and the finalisation of the list of medical specialties and subspecialties that should be used for the call for experts.

    EFORT has also been confirmed as observer in the subgroup Clinical Investigation and Evaluation (CIE) of the Medical Devices Coordination Group (MDCG).

    Earlier and through input and participation in SCENIHR Metal on Metal controversies were discussed.

    -European Commission issued Final Opinion on the Safety of Metal-on-Metal (MoM) Joint Replacements with a particular focus on hip implants – https://www.efort.org/eu_commission_mom/

    Other activities

    EFORT also organized an inaugural workshop "EFORT Implant & Patient Safety Initiative" which took place at the State Chancellery of Saxony at the Saxony Liaison Office in Brussels. This meeting gathered participants representing surgeons in orthopaedics and traumatology, manufacturers, notified bodies and representatives of the European Commission.

    EFORT also endorses the OECD PaRIS Hip and Knee Data Collection Guidelines along with ISOC, ISAR, NJR and World Confederation for Physical Therapy

  • Meetings

    Meetings

    None declared

Download this datacard